Google’s artificial intelligence firm DeepMind is already under investigation for its partnership with Royal Free London NHS Foundation Trust, and now is finding more trouble with a medical app it recently deployed, New Scientist reports. DeepMind’s Streams app monitors kidney conditions, but does not touch base with any relevant regulatory authority. New Scientist asks whether DeepMind should have gone through an ethical approval process for this type of data transfer before deploying Streams. Their investigation revealed the U.K.’s Medicines and Healthcare products Regulatory Agency guidelines count software as medical devices, and DeepMind did not obtain a “Notice of No Objection” from the MHRA, a requirement for any new medical device. Both Google and the NHS Trust say they are now in compliance with the rules.
Full Story